Pfizer, JetBlue, PayPal rise premarket; Merck, CrowdStrike, Diageo fall

Go back to Pfizer, JetBlue, PayPal rise premarket; Merck, CrowdStrike, Diageo fall

JMP Securities on CrowdStrike Holdings (CRWD): 'Investors Should Buy CRWD Here'

August 1, 2024 6:57 AM EDT

JMP Securities analyst Trevor Walsh reiterated a Market Outperform rating and $400.00 price target on CrowdStrike Holdings (NASDAQ: CRWD)

The analyst comments "Ahead of C2Q24 earnings, we discuss our thoughts on the CrowdStrike global IT outage (and our view on the opportunity this has created), Googles failed bid for Wiz, and Gartners new Single-Vendor SASE Magic Quadrant. We also share our mix of recent data points for the sector, including a total of 40 specific to the topic of the CrowdStrike IT outage. The median cybersecurity company in our coverage universe... More

PayPal (PYPL) PT Raised to $90 at Macquarie

July 31, 2024 8:50 AM EDT

Macquarie analyst Paul Golding raised the price target on PayPal (NASDAQ: PYPL) to $90.00 (from $85.00) while maintaining a Outperform rating.

The analyst comments "Another Q of beats to market expectations and guidance. This and July momentum still solid drives another upgrade to FY24... More

JPMorgan Reiterates Overweight Rating on PayPal (PYPL)

July 31, 2024 6:36 AM EDT

JPMorgan analyst Tien-tsin Huang reiterated an Overweight rating and $77.00 price target on PayPal (NASDAQ: PYPL).

The analyst comments "PayPal stock closed up ~9% (S&P 500 -1%) as 2Q results were well ahead of already heightened expectations since 1Q earnings against pressured stock valuation. Transaction margin dollar growth accelerated again to +8% (4% in 1Q; prior JPMe/Street flattish) on broad-based... More

Leidos Holdings (LDOS) PT Raised to $145 at RBC Capital

July 31, 2024 6:23 AM EDT

RBC Capital analyst Ken Herbert raised the price target on Leidos Holdings (NYSE: LDOS) to $145.00 (from $140.00) while maintaining a Sector Perform rating.

The analyst comments "Our view: Leidos Holdings (LDOS) reported strong 2Q24 results, with 2Q24 adj. EPS of $2.63. Revenue was $4.1B... More

Pfizer (PFE) PT Raised to $34 at Goldman Sachs

July 31, 2024 5:20 AM EDT

Goldman Sachs analyst Chris Shibutani raised the price target on Pfizer (NYSE: PFE) to $34.00 (from $31.00) while maintaining a Buy rating.

The analyst comments "Relative outperformance on the day (+2% vs. flat XLV) appears warranted in our view given solid 2Q results... More

CrowdStrike Holdings (CRWD) PT Lowered to $300 at Jefferies

July 31, 2024 5:13 AM EDT

Jefferies analyst Joseph Gallo lowered the price target on CrowdStrike Holdings (NASDAQ: CRWD) to $300.00 (from $400.00) while maintaining a Buy rating.

The analyst comments "News surfaced that Delta hired lawyers to sue CRWD & MSFT for IT outage damages. We don't expect CRWD to... More

Bernstein SocGen Group Upgrades PayPal (PYPL) to Outperform - First Time in Nearly Three Years

July 31, 2024 4:55 AM EDT

Bernstein SocGen Group analyst Harshita Rawat upgraded PayPal (NASDAQ: PYPL) from Market Perform to Outperform with a price target of $78.00 (from $71.00).

The analyst comments "We are tactically upgrading PayPal to OP after almost 3 years. We are encouraged by improved transaction gross profit performance from... More

PayPal (PYPL) PT Raised to $72 at Evercore ISI

July 30, 2024 12:43 PM EDT

Evercore ISI analyst David Togut raised the price target on PayPal (NASDAQ: PYPL) to $72.00 (from $70.00) while maintaining a In Line rating.

The analyst comments "PYPL raised full year 2024 adjusted EPS growth guidance to the lowto-mid-teens versus prior estimate of mid to high single digits,... More